News
Genentech, NVIDIA partner on ‘lab-in-a-loop’ AI platform Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) ...
Danish drugmaker Novo Nordisk must like what it has seen in its two-year-old alliance with gene-silencing specialist Dicerna Pharma – it has just agreed to acquire the biotech for $3.3 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback